A PBS review of COPD therapies has recommended a mix of prescribing restrictions to encourage spirometry and easing of criteria for starting some combination inhalers. The final report from the Post-market Review of Chronic Obstructive Pulmonary Disease (COPD) Medicines was released on 30 January, comprising 11 recommendations. As previously reported in the limbic, it includes ...
Already a member?
Enter your email to keep reading.